CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,013,000 | -17.5% | 100,000 | -11.4% | 1.45% | -11.1% |
| Q4 2016 | $12,135,000 | -13.6% | 112,867 | 0.0% | 1.64% | +5.6% |
| Q3 2016 | $14,050,000 | +17.1% | 112,867 | 0.0% | 1.55% | -9.0% |
| Q2 2016 | $12,000,000 | -6.0% | 112,867 | +1.2% | 1.70% | -11.5% |
| Q1 2016 | $12,765,000 | -19.6% | 111,500 | 0.0% | 1.92% | +1.2% |
| Q4 2015 | $15,884,000 | +58.6% | 111,500 | 0.0% | 1.90% | +18.8% |
| Q3 2015 | $10,015,000 | -22.0% | 111,500 | 0.0% | 1.60% | -6.3% |
| Q2 2015 | $12,840,000 | +75.7% | 111,500 | +45.8% | 1.71% | +51.2% |
| Q1 2015 | $7,307,000 | +20.8% | 76,500 | -15.0% | 1.13% | +21.0% |
| Q4 2014 | $6,051,000 | +18.0% | 90,000 | -5.3% | 0.93% | -11.5% |
| Q3 2014 | $5,126,000 | +15.3% | 95,000 | -5.0% | 1.05% | -10.5% |
| Q2 2014 | $4,447,000 | – | 100,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |